journal article Jan 26, 2012

Phacoemulsification and goniosynechialysis for the management of refractory acute angle closure

View at Publisher Save 10.5301/ejo.5000101
Abstract
Purpose To evaluate the effectiveness of phacoemulsification with goniosynechialysis in the management of refractory acute angle closure (AAC). Methods In this prospective, noncomparative interventional case series, patients with AAC who were unresponsive to medical and laser therapy were included. Success was defined as complete if intraocular pressure (IOP) had a drop of at least 30% and was between 6 and 21 mmHg without medication, and qualified if IOP was within that range with medication. Results A total of 24 patients with a mean age of 56 years (range 39-77) were treated. Mean follow-up time was 15.7±4.2 months (range 6-24). Mean preoperative and last visit IOPs were 34.27±7.23 mmHg and 17.5±3.21 mmHg, respectively (p<0.001). Mean number of glaucoma medication dropped from 3.67±0.48 to 0.63±1.05 (p<0.001). There was a positive correlation between the attack–surgery interval and last visit IOP (p<0.001, r=0.697). There was a negative correlation between the preoperative anterior chamber depth and last visit IOP drop (p=0.03, r=–0.56). Also, a positive correlation was found between the preoperative IOP and last visit IOP drop (p<0.001, r=0.896). At final visit, complete and qualified success was achieved in 17/24 (71%) and 5/24 (21%) cases, respectively. The most common intraoperative and postoperative complications were hyphema and anterior chamber fibrinous reaction, respectively. Conclusions Phacoemulsification with goniosynechialysis seems to be a safe and effective method for the management of patients with refractory AAC. This procedure can be considered for these patients before proceeding with filtering surgery.
Topics

No keywords indexed for this article. Browse by subject →

References
24
[1]
Tarongoy P. Surv Ophthalmol (2009) 10.1016/j.survophthal.2008.12.002
[2]
Ho C.L. Int Ophthalmol Clin (2004) 10.1097/00004397-200404410-00019
[3]
Silver D.M. J Glaucoma (2004) 10.1097/00061198-200404000-00004
[4]
Lowe R.F. Br J Ophthalmol (1972) 10.1136/bjo.56.5.409
[5]
Lowe R.F. Br J Ophthalmol (1970) 10.1136/bjo.54.3.161
[6]
Aung T. Ophthalmology (2000) 10.1016/s0161-6420(00)00137-8
[7]
Kubota T. Ophthalmologica (2003) 10.1159/000071346
[8]
Teekhasaenee C. Ophthalmology (1999) 10.1016/s0161-6420(99)90149-5
[9]
Imaizumi M. J Cataract Refract Surg (2006) 10.1016/j.jcrs.2005.11.014
[10]
Ming Zhi Z. Am J Ophthalmol (2003) 10.1016/s0002-9394(02)02108-6
[11]
Roberts T.V. J Cataract Refract Surg (2000) 10.1016/s0886-3350(00)00358-8
[12]
Wu J.H. Zhejiang Da Xue Xue Bao Yi Xue Ban (2008)
[13]
Harasymowycz P.J. J Glaucoma (2005) 10.1097/01.ijg.0000159131.38828.85
[14]
Jacobi P.C. Ophthalmology (2002) 10.1016/s0161-6420(02)01123-5
[15]
Hayashi K. Ophthalmology (2000) 10.1016/s0161-6420(00)00007-5
[16]
Zhuo Y.H. J Glaucoma (2009) 10.1097/ijg.0b013e31819c4322
[17]
Hayashi K. J Cataract Refract Surg (2001) 10.1016/s0886-3350(01)01036-7
[18]
Nonaka A. Ophthalmology (2005) 10.1016/j.ophtha.2004.12.042
[19]
Euswas A. J Med Assoc Thai (2005)
[20]
Nonaka A. Ophthalmology (2006) 10.1016/j.ophtha.2005.11.018
[21]
Issa S.A. Br J Ophthalmol (2005) 10.1136/bjo.2004.047662
[22]
Liu C.J. Arch Ophthalmol (2006) 10.1001/archopht.124.10.1390
[23]
Sihota R. Indian J Ophthalmol (2001)
[24]
Yoon J.Y. Korean J Ophthalmol (2003) 10.3341/kjo.2003.17.2.122
Related

You May Also Like

Blood-Retinal Barrier

José Cunha-Vaz, Rui Bernardes · 2010

450 citations

Dry Eye Syndrome-Related Quality of Life in Glaucoma Patients

Gemma Caterina Maria Rossi, Carmine Tinelli · 2009

148 citations

The new Myopic Traction Maculopathy Staging System

Barbara Parolini, Michele Palmieri · 2020

96 citations

Corneal Collagen Crosslinking for Corneal Ectasias: A Review

David P.S. O’Brart · 2016

65 citations